View in EDS HTML Full Text PDF Full Text

Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study.

Saved in:
Bibliographic Details
Title: Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study.
Authors: Bissonnette, R.1 rbissonnette@innovaderm.ca, Haydey, R.2, Rosoph, L. A.3, Lynde, C. W.4, Bukhalo, M.5, Fowler, J. F.6, Delorme, I.7, Gagné‐henley, A.8, Gooderham, M.9, Poulin, Y.10, Barber, K.11, Jenkin, P.12, Landells, I.13, Pariser, D. M.14
Source: Journal of the European Academy of Dermatology & Venereology. Mar2018, Vol. 32 Issue 3, p403-410. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09269959
DOI:10.1111/jdv.14647